ArticleCellular and molecular life sciences : CMLS2026
Metabolic fatty acid substrates enhance the structural and mechanical performance of human-induced pluripotent stem cell-derived cardiomyocytes.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer a powerful platform for disease modeling, drug discovery, and regenerative therapies. However, their clinical and research utility remains limited by their immature, fetal-like phenotype. In the human heart, postnatal metabolic maturation involves a critical switch from glycolysis to fatty acid β-oxidation, enabling efficient ATP production via oxidative phosphorylation. In this study, we investigated whether mimicking this metabolic shift in vitro by culturing hiPSC-CMs in a fatty acid-based maturation medium (FAM) could enhance their structural and functional development compared to a conventional glucose-based medium (GLM). hiPSC-CMs cultured in FAM for two weeks exhibited significant improvements in morphological, metabolic, and mechanical maturation markers. Morphologically, FAM-cultured CMs exhibited enhanced sarcomeric organization, increased cellular alignment, and a more elongated and rod-like shape, which are characteristics typically associated with mature CMs. Ultrastructural analysis further confirmed improved maturation, revealing more organized sarcomeres and densely packed mitochondria compared to GLM-cultured CMs. Metabolically, FAM-cultured CMs demonstrated a clear shift from glycolytic to oxidative metabolism, as evidenced by higher mitochondrial membrane potential, increased oxidative phosphorylation capacity, elevated ATP production, and reduced glycolytic activity. These metabolic adaptations indicate a more adult-like energy profile, consistent with enhanced fatty acid β-oxidation. Mechanically, FAM-cultured cardiomyocytes exhibited enhanced functional maturity, as evidenced by faster calcium transients and greater contraction amplitude, indicating improvements in specific electrophysiological properties. In conclusion, fatty acid supplementation effectively promotes the structural, metabolic, and mechanical maturation of hiPSC-CMs, resulting in a more adult-like phenotype. This strategy provides a robust and straightforward approach to enhance the physiological relevance of hiPSC-CMs for preclinical applications in disease modeling, drug testing, and regenerative medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.